EP1021462A1 - Test für kernrezeptor-liganden unter verwendung von fret - Google Patents
Test für kernrezeptor-liganden unter verwendung von fretInfo
- Publication number
- EP1021462A1 EP1021462A1 EP98956094A EP98956094A EP1021462A1 EP 1021462 A1 EP1021462 A1 EP 1021462A1 EP 98956094 A EP98956094 A EP 98956094A EP 98956094 A EP98956094 A EP 98956094A EP 1021462 A1 EP1021462 A1 EP 1021462A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- nuclear receptor
- binding domain
- ligand binding
- cbp
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Definitions
- the nuclear receptor co-activator is human SRC-1 and the binding portion includes a contiguous stretch of amino acids of human SRC-1 selected from the group consisting of: positions 45-53, 632-640, 689-696, 748-755, and 1434-1441.
- a nuclear receptor or ligand binding domain thereof labeled with a first fluorescent reagent (a) a nuclear receptor or ligand binding domain thereof labeled with a first fluorescent reagent; (b) CBP, p300, or other nuclear receptor co-activator, or a binding portion thereof, labeled with a second fluorescent reagent; (c) an agonist of the nuclear receptor; and
- FRET donor-acceptor pairs are suitable for the practice of the present invention.
- the following donor- acceptor pairs can be used: dansyl/fluorescein; fluorescein/rhodamine; tryptophan/aminocoumarin.
- Human PPAR ⁇ 2 contains the same amino acid sequence as human PPAR ⁇ l except for an amino terminal addition of 24 amino acids (see Elbrecht et al., 1996, Biochem. Biophys. Res. Comm. 224:431-437).
- hCBPl-113 was directly labeled with europium cryptate (Eu3+K); hPPAR ⁇ lLBD was indirectly labeled with
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6138597P | 1997-10-07 | 1997-10-07 | |
US61385P | 1997-10-07 | ||
PCT/US1998/021049 WO1999018124A1 (en) | 1997-10-07 | 1998-10-06 | Assays for nuclear receptor ligands using fret |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1021462A1 true EP1021462A1 (de) | 2000-07-26 |
EP1021462A4 EP1021462A4 (de) | 2005-04-13 |
Family
ID=22035450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98956094A Withdrawn EP1021462A4 (de) | 1997-10-07 | 1998-10-06 | Test für kernrezeptor-liganden unter verwendung von fret |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1021462A4 (de) |
JP (1) | JP2001519525A (de) |
CA (1) | CA2305711A1 (de) |
WO (1) | WO1999018124A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000025134A1 (en) * | 1998-10-23 | 2000-05-04 | Glaxo Group Limited | Assays for ligands for nuclear receptors |
ES2326850T3 (es) * | 1998-12-23 | 2009-10-20 | Glaxo Group Limited | Ensayos para ligandos de receptores nucleares. |
WO2001020326A2 (en) * | 1999-09-13 | 2001-03-22 | Equitech Laboratories, Inc. | Materials and methods for the determination of an analyte |
WO2001040805A1 (en) * | 1999-11-30 | 2001-06-07 | Akzo Nobel N.V. | Steroid compounds for steroid receptor binding assays |
WO2001071352A2 (en) * | 2000-03-17 | 2001-09-27 | The Salk Institute For Biological Studies | Compositions associated with complex formation |
US7198924B2 (en) | 2000-12-11 | 2007-04-03 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
US6924311B2 (en) | 2001-10-17 | 2005-08-02 | X-Ceptor Therapeutics, Inc. | Methods for affecting various diseases utilizing LXR compounds |
EP1310799B1 (de) | 2001-11-07 | 2005-12-21 | Schering AG | In vitro Screening nach Liganden des Östrogenrezeptors |
EP1552299A4 (de) * | 2002-07-24 | 2006-09-06 | Johnson & Johnson Pharm Res | Verfahren zur identifizierung von liganden |
JP4511363B2 (ja) | 2002-11-07 | 2010-07-28 | エラスムス ユニフェルシテイト ロッテルダム | 相互作用する分子を検出するためのfretプローブおよび方法 |
JP4803976B2 (ja) * | 2003-07-09 | 2011-10-26 | 独立行政法人科学技術振興機構 | 細胞内ip3測定用分子センサー |
KR20060121842A (ko) | 2003-08-28 | 2006-11-29 | 주식회사 중외제약 | β-카테닌/TCF에 의해 활성화되는 전사의 조절 |
EP2287341B1 (de) | 2003-12-01 | 2013-02-13 | Life Technologies Corporation | Rekombinationsstellen enthaltende Nukleinsäuremoleküle und Verfahren zur Verwendung davon |
US20080286260A1 (en) * | 2004-03-26 | 2008-11-20 | Bayer Healthcare Ag | Diagnostic and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Alpha (Ppara) |
KR100704011B1 (ko) | 2005-02-16 | 2007-04-04 | 한국과학기술원 | 금속나노입자와 양자점의 fret에 의한 생체분자특이결합 검출 방법 |
JP4936476B2 (ja) * | 2005-06-28 | 2012-05-23 | 第一三共株式会社 | Lxrリガンドの試験方法 |
JP5264421B2 (ja) | 2007-11-22 | 2013-08-14 | 富士フイルム株式会社 | 被験物測定用担体およびその製造方法 |
WO2009141926A1 (ja) * | 2008-05-23 | 2009-11-26 | 国立大学法人東京大学 | 糖代謝・脂質代謝に作用する化合物の取得方法 |
CN106574296B (zh) * | 2014-04-14 | 2021-03-02 | 耶路撒冷希伯来大学伊森姆研究发展公司 | 用于测定dna的组织或细胞来源的方法和试剂盒 |
CN110168099B (zh) | 2016-06-07 | 2024-06-07 | 加利福尼亚大学董事会 | 用于疾病和病症分析的无细胞dna甲基化模式 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997040378A1 (en) * | 1996-04-19 | 1997-10-30 | Vereniging Het Nederlands Kanker Instituut | Interaction of cyclin d1 and estrogen receptor and its use in assays |
WO1998056806A1 (en) * | 1997-06-12 | 1998-12-17 | The Regents Of The University Of California | A TRANSCRIPTION FACTOR COACTIVATOR PROTEIN, p/CIP |
WO1999041608A2 (en) * | 1998-02-12 | 1999-08-19 | Prolifix Limited | Interaction between cyclin d1 and steroid receptor co-activators |
-
1998
- 1998-10-06 JP JP2000514931A patent/JP2001519525A/ja active Pending
- 1998-10-06 WO PCT/US1998/021049 patent/WO1999018124A1/en active Application Filing
- 1998-10-06 EP EP98956094A patent/EP1021462A4/de not_active Withdrawn
- 1998-10-06 CA CA002305711A patent/CA2305711A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997040378A1 (en) * | 1996-04-19 | 1997-10-30 | Vereniging Het Nederlands Kanker Instituut | Interaction of cyclin d1 and estrogen receptor and its use in assays |
WO1998056806A1 (en) * | 1997-06-12 | 1998-12-17 | The Regents Of The University Of California | A TRANSCRIPTION FACTOR COACTIVATOR PROTEIN, p/CIP |
WO1999041608A2 (en) * | 1998-02-12 | 1999-08-19 | Prolifix Limited | Interaction between cyclin d1 and steroid receptor co-activators |
Non-Patent Citations (10)
Title |
---|
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 22 July 1997 (1997-07-22), BELLANGER L ET AL: "Homogeneous time-resolved fluoroimmunoassay for cardiac troponin-I using TRACE technology" XP008042758 Database accession no. PREV199799633726 & CLINICAL CHEMISTRY, vol. 43, no. 6 PART 2, 1997, page S159, 49TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY; ATLANTA, GEORGIA, USA; JULY 20-24, 1997 ISSN: 0009-9147 * |
KOLB A J ET AL: "HOMOGENEOUS, TIME-RESOLVED FLUORESCENCE METHOD FOR DRUG DISCOVERY" 1997, HIGH-THROUGHPUT SCREENING, THE DISCOVERY OF BIOACTIVE SUBSTANCES, XX, XX, PAGE(S) 345-360 , XP008042717 * page 354, paragraph 5 - page 355, paragraph 1; figure 12 * * |
KOLB J M ET AL: "USE OF A NOVEL HOMOGENEOUS FLUORESCENT TECHNOLOGY IN HIGH THROUGHPUT SCREENING" JOURNAL OF BIOMOLECULAR SCREENING, LARCHMONT, NY, US, vol. 1, no. 4, 1996, pages 203-210, XP008042702 ISSN: 1087-0571 * |
LEE S P ET AL: "CHARACTERIZATION OF ENDONUCLEOLYTIC ACTIVITY OF HIV-1 INTEGRASE USING A FLUOROGENIC SUBSTRATE" ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 227, 1995, pages 295-301, XP002945389 ISSN: 0003-2697 * |
MATHIS G: "PROBING MOLECULAR INTERACTIONS WITH HOMOGENEOUS TECHNIQUES BASED ONRARE EARTH CRYPTATES AND FLUORESCENCE ENERGY TRANSFER" CLINICAL CHEMISTRY, vol. 41, no. 9, 1995, pages 1391-1397, XP001018128 ISSN: 0009-9147 * |
ROGERS M V: "LIGHT ON HIGH-THROUGHPUT SCREENING: FLUORESCENCE-BASED ASSAY TECHNOLOGIES" DRUG DISCOVERY TODAY, ELSEVIER SCIENCE LTD, GB, vol. 2, no. 4, April 1997 (1997-04), pages 156-160, XP002916138 ISSN: 1359-6446 * |
ROGERS: "Light on high-throughput screening: fluorescence-based assay technologies" DRUG DISCOVERY TODAY, vol. 2, no. 4, April 1997 (1997-04), pages 156-160, XP002916138 * |
See also references of WO9918124A1 * |
VOEGEL, HEINE, ZECHEL, CHAMBON, GRONEMEYER: "TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors" EMBO JOURNAL, vol. 15, no. 14, 1996, pages 3667-3675, XP002045757 * |
ZHOU G ET AL: "Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation" METHODS : A COMPANION TO METHODS IN ENZYMOLOGY, ACADEMIC PRESS INC., NEW YORK, NY, US, vol. 25, no. 1, September 2001 (2001-09), pages 54-61, XP002267175 ISSN: 1046-2023 * |
Also Published As
Publication number | Publication date |
---|---|
EP1021462A4 (de) | 2005-04-13 |
JP2001519525A (ja) | 2001-10-23 |
WO1999018124A1 (en) | 1999-04-15 |
CA2305711A1 (en) | 1999-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999018124A1 (en) | Assays for nuclear receptor ligands using fret | |
US6689574B1 (en) | Assays for nuclear receptor agonists and antagonists using fluorescence resonance energy transfer | |
KR20090083925A (ko) | 탐지시스템 및 그 이용 | |
EP1057896B1 (de) | Verfahren zur identifizierug oder testung von agonisten für bzw. antagonisten gegen ppar | |
Bröer | Xenopus laevis oocytes | |
Vollmer et al. | Subcellular compartmentalization of activation and desensitization of responses mediated by NK2 neurokinin receptors | |
WO2006122077A2 (en) | Method of screening for drugs that block ligand binding to a lipid binding protein | |
JP2005507667A (ja) | Gタンパク質共役受容体媒介活性の新規細胞系アッセイ | |
Graham et al. | Ligand binding by recombinant domains from insect ecdysone receptors | |
US7604959B2 (en) | Cell-based assays employing voltage and calcium dyes | |
Zhou et al. | Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation | |
Gidon et al. | Studying the regulation of endosomal cAMP production in GPCR signaling | |
Crouch et al. | New strategies in drug discovery for GPCRs: high throughput detection of cellular ERK phosphorylation | |
Fay et al. | Purification of functional CB1 and analysis by site-directed fluorescence labeling methods | |
US7767409B2 (en) | Method for detection of substance bound to nuclear receptor | |
US20060110732A1 (en) | Method for the identification of ligands | |
EP3732486A1 (de) | Verfahren zur quantifizierung der cftr-proteinexpression | |
US20030039980A1 (en) | Assays for determination of functional binding of compounds to receptors | |
JP4848282B2 (ja) | 電位色素及びカルシウム色素を用いた新規の細胞ベースアッセイ | |
Chen et al. | Application of large-scale transient transfection to cell-based functional assays for ion channels and GPCRs | |
Mancini et al. | Exploring the Technology Landscape of 7TMR Drug Signaling Profiling | |
US20070218475A1 (en) | Efficient drug screening for protein targets | |
EP1552299A2 (de) | Verfahren zur identifizierung von liganden | |
Frauli et al. | Molecular Biology Techniques Applied to GPCR Allosteric and Biased Ligands | |
Fay et al. | Purification and Analysis of by Functional Site-Directed CB1 Fluorescence Labeling Methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000508 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050225 |
|
17Q | First examination report despatched |
Effective date: 20060915 |
|
17Q | First examination report despatched |
Effective date: 20060915 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20071204 |